ZyVersa Therapeutics, Inc. (ZVSA) SEC Filings & Financial Intelligence
ZyVersa Therapeutics, Inc. (ZVSA) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ZVSA
CIK: 1859007
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerNina Quarequio
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-07-16 | 2026-07-16 | 8-K | 0001493152-26-033565 | View SEC Doc Filr Page |
| 8-K | 2026-07-10 | 2026-07-08 | 8-K | 0001493152-26-032851 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001493152-26-022759 | View SEC Doc Filr Page |
| 10-K | 2026-03-31 | 2025-12-31 | 10-K | 0001493152-26-014271 | View SEC Doc Filr Page |
| 8-K | 2026-03-05 | 2026-02-27 | 8-K | 0001493152-26-008994 | View SEC Doc Filr Page |
| 8-K | 2025-12-03 | 2025-12-02 | 8-K | 0001493152-25-025966 | View SEC Doc Filr Page |
| 8-K | 2025-11-19 | 2025-11-19 | 8-K | 0001493152-25-024273 | View SEC Doc Filr Page |
| 10-Q | 2025-11-19 | 2025-09-30 | 10-Q | 0001493152-25-024263 | View SEC Doc Filr Page |
| NT 10-Q | 2025-11-14 | 2025-09-30 | NT 10-Q | 0001493152-25-023612 | View SEC Doc Filr Page |
| 8-K | 2025-10-15 | 2025-10-10 | 8-K | 0001493152-25-018156 | View SEC Doc Filr Page |
| 25-NSE | 2025-10-06 | — | 25-NSE Filing | 0001354457-25-000988 | View SEC Doc Filr Page |
| 8-K | 2025-09-18 | 2025-09-14 | 8-K | 0001493152-25-013968 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-25-003603 | View SEC Doc Filr Page |
| 10-Q | 2025-08-13 | 2025-06-30 | 10-Q | 0001641172-25-023342 | View SEC Doc Filr Page |
| EFFECT | 2025-08-06 | — | EFFECT Filing | 9999999995-25-002497 | View SEC Doc Filr Page |
| CORRESP | 2025-08-05 | — | CORRESP Filing | 0001641172-25-022236 | View SEC Doc Filr Page |
| CORRESP | 2025-08-01 | — | CORRESP Filing | 0001641172-25-021954 | View SEC Doc Filr Page |
| S-1/A | 2025-08-01 | — | S-1/A | 0001641172-25-021952 | View SEC Doc Filr Page |
| UPLOAD | 2025-07-30 | — | UPLOAD Filing | 0000000000-25-008006 | View SEC Doc Filr Page |
| 8-K | 2025-07-28 | 2025-07-25 | 8-K | 0001641172-25-021100 | View SEC Doc Filr Page |
| S-1/A | 2025-07-18 | — | S-1/A | 0001641172-25-020253 | View SEC Doc Filr Page |
| 4 | 2025-07-16 | 2025-07-11 | 4 Filing | 0001641172-25-019858 | View SEC Doc Filr Page |
| 8-K | 2025-07-16 | 2025-07-15 | 8-K | 0001641172-25-019856 | View SEC Doc Filr Page |
| 4 | 2025-07-15 | 2025-07-11 | 4 Filing | 0001641172-25-019724 | View SEC Doc Filr Page |
| 4 | 2025-07-15 | 2025-07-11 | 4 Filing | 0001641172-25-019725 | View SEC Doc Filr Page |